Effects of vpu start-codon mutations on human immunodeficiency virus type 1 replication in macrophages

Journal of General Virology

Volumn 88, Issue 10, 2007, Pages 2780-2792

  Richards, Kathryn H ^a   Clapham, Paul R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; RNA DIRECTED DNA POLYMERASE; VIRUS ENVELOPE PROTEIN; VPU PROTEIN;

ARTICLE; BRAIN TISSUE; CELL CULTURE; CHIMERA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IN VIVO STUDY; MACROPHAGE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; START CODON; VIRION; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS REPLICATION; WILD TYPE;

CELL LINE; CELLS, CULTURED; CLONING, MOLECULAR; CODON; GENE PRODUCTS, VPU; GENOME, VIRAL; HIV CORE PROTEIN P24; HIV-1; HUMANS; KIDNEY; MACROPHAGES; POLYMORPHISM, SINGLE NUCLEOTIDE; RESTRICTION MAPPING; RNA-DIRECTED DNA POLYMERASE; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

CITRUS MAXIMA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 35048874631     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83120-0     Document Type: Article

References (62)

1. Abada, P., Noble, B. & Cannon, P. M. (2005). Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production. J Virol 79, 3627-3638.
2. Adachi, A., Miyaura, M., Sakurai, A., Yoshida, A., Koyama, A. H. & Fujita, M. (2001). Growth characteristics of SHIV without the vpu gene. Int J Mol Med 8, 641-644.
3. Balliet J. W., Kolson, D. L., Eiger, G., Kim, F. M., McGann, K. A., Srinivasan, A. & Coliman, R. (1994). Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef. mutational analysis of a primary HIV-1 isolate. Virology 200, 623-631.
4. Bannert, N., Schenten, D., Craig, S. & Sodroski, J. (2000). The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses. J Virol 74, 10984-10993.
5. βTrCP substrates. J Biol Chem 279, 788-795.
6. Bour, S. & Strebel, K. (1996). The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. J Virol 70, 8285-8300.
7. Bour, S., Schubert, U. & Strebel, K. (1995). The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation. J Virol 69, 1510-1520.
8. Bour, S., Schubert U., Peden, K. & Strebel, K. (1996). The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor? J Virol 70, 820-829.
9. Brown, A., Moghaddam, S., Kawano, T. & Cheng-Mayer, C. (2004). Multiple human immunodeficiency virus type 1 Nef functions contribute to efficient replication in primary human macrophages. J Gen Virol 85, 1463-1469.
10. Callahan, M. A., Handley, M. A., Lee, Y. H., Talbot K. J., Harper, J. W. & Panganiban, A. T. (1998). Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family. J Virol 72, 5189-5197.
11. Cheng-Mayer, C., Quiroga, M., Tung, J. W., Dina, D. & Levy, J. A. (1990). Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J Virol 64, 4390-4398.
12. Cohen, E. A., Terwilliger, E. F., Sodroski, J. G. & Haseltine, W. A. (1988). Identification of a protein encoded by the vpu gene of HIV-1. Nature 334, 532-534.
13. Dejucq, N., Simmons, G. & Clapham, P. R. (2000). T-cell line adaptation of human immunodeficiency virus type 1 strain SF162: effects on envelope, vpu and macrophage-tropism. J Gen Virol 81, 2899-2904.
14. DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P. M., Miller, J. H. & Calos, M. P. (1987). Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7, 379-387.
15. Ewart, G. D., Sutherland, T., Gage, P. W. & Cox, G. B. (1996). The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J Virol 70, 7108-7115.
16. Fujita, K, Omura, S. & Silver, J. (1997). Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors. J Gen Virol 78, 619-625.
17. Gendelman, H. E., Orenstein, J. M., Martin, M. A., Ferrua, C., Mitra, R., Phipps, T., Wahl, L. A., Lane, H. C., Fauci, A. S. & Burke, D. S. (1988). Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 167, 1428-1441.
18. Greenberg, M. E., Bronson, S., Lock, M., Neumann, M., Pavlakis, G. N. & Skowronski, J. (1997). Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J 16, 6964-6976.
19. Handley, M. A., Paddock, S., Dail, A. & Panganiban, A. T. (2001). Association of Vpu-binding protein with microtubules and Vpu-dependent redistribution of HIV-1 Gag protein. Virology 291, 198-207.
20. KU-1bMC33) susceptible to rimantadine. Virology 348, 449-461.
21. Hsu, K., Seharaseyon, J., Dong, P., Bour, S. & Marban, E (2004). Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel. Mol Cell 14, 259-267.
22. Iida, S., Fukumori, T., Oshima, Y., Akari, H., Koyama, A. H. & Adachi, A. (1999). Compatibility of Vpu-like activity in the four groups of primate immunodeficiency viruses. Virus Genes 18, 183-187.
23. Kawamura, M., Ishizaki, T., Ishimoto, A., Shioda, T., Kitamura, T. & Adachi, A. (1994). Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures. J Gen Virol 75, 2427-2431.
24. Kimura, T., Nishikawa, M. & Ohyama, A. (1994). Intracellular membrane traffic of human immunodeficiency virus type 1 envelope glycoproteins: vpu liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum. J Biochem (Tokyo) 115, 1010-1020.
25. Lee, B., Sharron, M., Montaner, L. J., Weissman, D. & Doms, R. W. (1999). Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A 96, 5215-5220.
26. Lenburg, M. E. & Landau, N. R. (1993). Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4. J Virol 67, 7238-7245.
27. Li, Y., Kappes, J. C., Conway, J. A., Price, R. W., Shaw, G. M. & Hahn, B. H. (1991). Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J Virol 65, 3973-3985.
28. Lindwasser, O. W., Chaudhuri, R. & Bonifacino, J. S. (2007). Mechanisms of CD4 downregulation by the Nef and Vpu proteins of primate immunodeficiency viruses. Curr Mol Med 7, 171-184.
29. Margottin, F., Bour, S. P., Durand, H, Selig, L., Benichou, S., Richard, V., Thomas, D., Strebel, K. & Benarous, R. (1998). A novel human WD protein, h-βTrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell 1, 565-574.
30. Mori, K., Ringler, D. J. & Desrosiers, R. C. (1993). Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry. J Virol 67, 2807-2814.
31. Neil, S. J., Eastman, S. W., Jouvenet N. & Bieniasz, P. D. (2006). HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLoS Pathog 2, e39.
32. Noble, B., Abada, P., Nunez-Iglesias, J. & Cannon, P. M. (2006). Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release. J Virol 80, 2924-2932.
33. O'Doherty, U., Swiggard, W. J. & Malim, M. H. (2000). Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 74, 10074-10080.
34. Pacyniak, E., Gomez, M. L., Gomez, L. M., Mulcahy, E. R., Jackson, M., Hout, D. R., Wisdom, B. J. & Stephens, E. B. (2005). Identification of a region within the cytoplasmic domain of the subtype B Vpu protein of human immunodeficiency virus type I (HIV-1) that is responsible for retention in the Golgi complex and its absence in the Vpu protein from a subtype C HIV-1. AIDS Res Hum Retroviruses 21, 379-394.
35. Pelchen-Matthews, A., Kramer, B. & Marsh, M. (2003). Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol 162, 443-455.
36. Peters, P. J., Sullivan, W. M., Duenas-Decamp, M. J., Bhattacharya, J., Ankghuambom, C., Brown, R., Luzuriaga, K, Bell, J., Simmonds, P. & other authors (2006). Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis. J Virol 80, 6324-6332.
37. Piguet, V., Chen, Y. L., Mangasarian, A., Foti, M., Carpentier, J. L. & Trono, D. (1998). Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes. EMBO J 17, 2472-2481.
38. Piguet V., Gu, F., Foti, M., Demaurex, N., Gruenberg, J., Carpentier, J. L. & Trono, D. (1999). Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of β-COP in endosomes. Cell 97, 63-73.
39. Sakai, H., Tokunaga, K, Kawamura, M. & Adachi, A. (1995). Function of human immunodeficiency virus type 1 Vpu protein in various cell types. J Gen Virol 76, 2717-2722.
40. Schubert, U., Henklein, P., Boldyreff, B., Wingender, E., Strebel, K. & Porstmann, T. (1994). The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted α-helix-turn-α-helix-motif J Mol Biol 236, 16-25.
41. Schubert U., Clouse, K. A. & Strebel, K. (1995). Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J Virol 69, 7699-7711.
42. Schubert, U., Bour, S., Ferrer-Montiel, A. V., Montal, M., Maldarell, F. & Strebel, K. (1996a). The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J Virol 70, 809-819.
43. Schubert, U., Ferrer-Montiel, A. V., Oblatt-Montal, M., Henklein, P., Strebel, K. & Montal, M. (1996b). Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett 398, 12-18.
44. Schubert, U., Anton, L. C., Bacik, I., Cox, J. H., Bour, S., Bennink, J. R., Orlowski, M., Strebel, K. & Yewdell, J. W. (1998). CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J Virol 72, 2280-2288.
45. Schubert U., Bour, S., Willey, R. L. & Strebel, K. (1999). Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env. J Virol 73, 887-896.
46. Schwartz, S., Felber, B. K., Fenyo, E. M. & Pavlakis, G. N. (1990). Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J Virol 64, 5448-5456.
47. Schwartz, S., Felber, B. K. & Pavlakis, G. N. (1992). Mechanism of translation of monocistronic and multicistronic human immuno-deficiency virus type 1 mRNAs. Mol Cell Biol 12, 207-219.
48. Sharova, N., Swingler, C., Sharkey, M. & Stevenson, M. (2005). Macrophages archive HIV-1 virions for dissemination in trans. EMBO J 24, 2481-2489.
49. Simmons, G., McKnight A., Takeuchi, Y., Hoshino, H. & Clapham, P. R. (1995). Cell-to-cell fusion, but not virus entry in macrophages by T-cell line tropic HIV-1 strains: a V3 loop-determined restriction. Virology 209, 696-700.
50. Simmons, G., Wilkinson, D., Reeves, J. D., Dittmar, M. T., Beddows, S., Weber, J., Carnegie, G., Desselberger, U., Gray, P. W. & other authors (1996). Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 70, 8355-8360.
51. Simmons, G., Reeves, J. D., McKnight, A., Dejucq, N., Hibbitts, S., Power, C. A., Aarons, E., Schols, D., Clercq, E. D. & other authors (1998). CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J Virol 72, 8453-8457.
52. Soda, Y., Shimizu, N., Jinno, A., Liu, H. Y., Kanbe, K., Kitamura, T. & Hoshino, H. (1999). Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line. Biochem Biophys Res Commun 258, 313-321.
53. Stephens, E. B., McCormick, C., Pacyniak, E., Griffin, D., Pinson, D. M., Sun, F., Nothnick, W., Wong, S. W., Gunderson, R. & other authors (2002). Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques. Virology 293, 252-261.
54. Swingler, S., Brichacek, B., Jacque, J. M., Ulich, C., Zhou, J. & Stevenson, M. (2003). HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 424, 213-219.
55. Theodore, T. S., Englund, G., Buckler-White, A., Buckler, C. E., Martin, M. A. & Peden, K. W. (1996). Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions. AIDS Res Hum Retroviruses 12, 191-194.
56. Thomas, E. R., Dunfee, R. L., Stanton, J., Bogdan, D., Kunstman, K., Wolinsky, S. M. & Gabuzda, D. (2007). High frequency of defective vpu compared with tat and rev genes in brain from patients with HIV type I-associated dementia. AIDS Res Hum Retroviruses 23, 575-580.
57. Varthakavi, V., Smith, R. M., Sour, S. P., Strebel, K. & Spearman, P. (2003). Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production. Proc Natl Acad Sci U S A 100, 15154-15159.
58. Varthakavi, V., Smith, R. M., Martin, K. L., Derdowski, A., Lapierre, L. A., Goldenring, J. R. & Spearman, P. (2006). The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release. Traffic 7, 298-307.
59. Vincent, M. J., Raja, N. U. & Jabbar, M. A. (1993). Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum. J Virol 67, 5538-5549.
60. Westervelt, P., Trowbridge, D. B., Epstein, L. G., Blumberg, B. M., Li, Y., Hahn, B. H., Shaw, G. M., Price, R. W. & Ratner, L. (1992). Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol 66, 2577-2582.
61. Willey, R. L., Maldarelli, F., Martin, M. A. & Strebel, K. (1992). Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J Virol 66, 226-234.
62. Yao, X. J., Friborg, J., Checroune, F., Gratton, S., Boisvert, F., Sekaly, R. P. & Cohen, E. A. (1995). Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity. Virology 209, 615-623.